Keywords: japan, cholesterol-lowering, drug, sector, set, grow, 5b

Japan's cholesterol-lowering drug sector set to grow 120% to 408.5B yen in 2017

Article | 07 April 2009

• Print This

Japanese sales of antihyperlipidemics, ie cholesterol-lowering drugs, will increase 120% to 408.5 billion yen ($4.04 million) in 2017 from 340.4 billion yen in 2008, according to ...

Enjoying this article? To continue reading you need to login or subscribe.